Trials / Completed
CompletedNCT03134534
Robot-assisted vs VATS Lobectomy for NSCLC
The Study of Robotic-assisted Thoracoscopic Lobectomy Versus Video-assisted Thoracoscopic Lobectomy for Non-small Cell Lung Cancer (RVlob)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Robot-assisted thoracoscopic surgery (RATS) was widely used in thoracic surgery, the surgical safety and feasibility of RATS lobectomy for NSCLC has been confirmed. However, the oncological long-term outcomes of RATS lobectomy has not been studied by randomized controlled trial, the purpose of this study is to determine whether RATS lobectomy would be as effective as VATS lobectomy on short-term and long-term outcomes.
Detailed description
Video-assisted thoracoscopic surgery (VATS) lobectomy is recommended for non small cell lung cancer (NSCLC) with surgical indications in China, its oncological long-term outcomes has been widely approved. As a new form of VATS, robot-assisted thoracoscopic surgery (RATS) was widely used in thoracic surgery, the 3D vision and flexible robot arm were helpful for surgeons to perform precise operations, and RATS was reported to bring extra benefits to patients. The surgical safety and feasibility of RATS lobectomy for NSCLC has been confirmed. However, the oncological long-term outcomes of RATS lobectomy has not been studied by randomized controlled trial. so we designed this randomized controlled trial to determine whether RATS lobectomy would be as effective as VATS lobectomy on short-term and long-term outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | VATS lobectomy | a minimal invasive surgical types for NSCLC: VATS lobectomy |
| PROCEDURE | RATS lobectomy | a minimal invasive surgical types for NSCLC: RATS lobectomy |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2017-05-01
- Last updated
- 2023-10-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03134534. Inclusion in this directory is not an endorsement.